Cargando…

Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway

The involvement of vascular endothelial injury with the pathophysiological process of heart failure has been identified. Baicalein (BAI), a flavonoid extracted from the root of Scutellaria baicalensis, is reported to exert antibacterial, antiviral, antithrombotic and antioxidant effects. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Chun-Xia, Xu, Man, Huang, Si-Hui, Wu, Qing-Qing, Yuan, Yuan, Deng, Wei, Tang, Qi-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783530/
https://www.ncbi.nlm.nih.gov/pubmed/29257294
http://dx.doi.org/10.3892/mmr.2017.8266
_version_ 1783295299220930560
author Wan, Chun-Xia
Xu, Man
Huang, Si-Hui
Wu, Qing-Qing
Yuan, Yuan
Deng, Wei
Tang, Qi-Zhu
author_facet Wan, Chun-Xia
Xu, Man
Huang, Si-Hui
Wu, Qing-Qing
Yuan, Yuan
Deng, Wei
Tang, Qi-Zhu
author_sort Wan, Chun-Xia
collection PubMed
description The involvement of vascular endothelial injury with the pathophysiological process of heart failure has been identified. Baicalein (BAI), a flavonoid extracted from the root of Scutellaria baicalensis, is reported to exert antibacterial, antiviral, antithrombotic and antioxidant effects. The aim of the present study was to investigate the effects of BAI on lipopolysaccharide (LPS)-induced vascular endothelial injury. Human umbilical vein endothelial cells (HUVECs) were stimulated by LPS (10 µM) in the presence or absence of BAI. The expressions of the inflammatory cytokines interleukin (IL)-lβ, IL-6, tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) were analyzed by reverse transcription-quantitative polymerase chain reaction, western blotting and enzyme-linked immunosorbent assay. Cell apoptosis was assessed by flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The results showed that BAI significantly inhibited the LPS-induced inflammatory response and apoptosis in HUVECs. BAI suppressed the LPS-induced upregulation of IL-1β, IL-6, TNF-α and MCP-1. Furthermore, BAI decreased the expression of B-cell lymphoma 2 (Bcl-2)-associated X protein and cleaved caspase-3; however, it increased the protein level of Bcl-2. The inhibitory effect of BAI may occur through the suppression of the Toll-like receptor 4 (TLR4)/phosphorylated (p)-transforming growth factor β-activated kinase 1/tumor necrosis factor receptor-associated family member associated nuclear factor (NF)-κB activator-binding kinase 1 (p-TBK1)/NF-κB signaling pathway. An increase in the level of p-TBK1 by MRT67307 abolished the effect of BAI on p-p65. In conclusion, the results of the present research suggested that BAI ameliorated endothelial cell injury associated with TLR4/NF-κB signaling, and highlighted the potential clinical use of BAI in blocking endothelial dysfunction and preventing heart failure.
format Online
Article
Text
id pubmed-5783530
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57835302018-02-12 Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway Wan, Chun-Xia Xu, Man Huang, Si-Hui Wu, Qing-Qing Yuan, Yuan Deng, Wei Tang, Qi-Zhu Mol Med Rep Articles The involvement of vascular endothelial injury with the pathophysiological process of heart failure has been identified. Baicalein (BAI), a flavonoid extracted from the root of Scutellaria baicalensis, is reported to exert antibacterial, antiviral, antithrombotic and antioxidant effects. The aim of the present study was to investigate the effects of BAI on lipopolysaccharide (LPS)-induced vascular endothelial injury. Human umbilical vein endothelial cells (HUVECs) were stimulated by LPS (10 µM) in the presence or absence of BAI. The expressions of the inflammatory cytokines interleukin (IL)-lβ, IL-6, tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) were analyzed by reverse transcription-quantitative polymerase chain reaction, western blotting and enzyme-linked immunosorbent assay. Cell apoptosis was assessed by flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The results showed that BAI significantly inhibited the LPS-induced inflammatory response and apoptosis in HUVECs. BAI suppressed the LPS-induced upregulation of IL-1β, IL-6, TNF-α and MCP-1. Furthermore, BAI decreased the expression of B-cell lymphoma 2 (Bcl-2)-associated X protein and cleaved caspase-3; however, it increased the protein level of Bcl-2. The inhibitory effect of BAI may occur through the suppression of the Toll-like receptor 4 (TLR4)/phosphorylated (p)-transforming growth factor β-activated kinase 1/tumor necrosis factor receptor-associated family member associated nuclear factor (NF)-κB activator-binding kinase 1 (p-TBK1)/NF-κB signaling pathway. An increase in the level of p-TBK1 by MRT67307 abolished the effect of BAI on p-p65. In conclusion, the results of the present research suggested that BAI ameliorated endothelial cell injury associated with TLR4/NF-κB signaling, and highlighted the potential clinical use of BAI in blocking endothelial dysfunction and preventing heart failure. D.A. Spandidos 2018-02 2017-12-12 /pmc/articles/PMC5783530/ /pubmed/29257294 http://dx.doi.org/10.3892/mmr.2017.8266 Text en Copyright: © Wan et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wan, Chun-Xia
Xu, Man
Huang, Si-Hui
Wu, Qing-Qing
Yuan, Yuan
Deng, Wei
Tang, Qi-Zhu
Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
title Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
title_full Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
title_fullStr Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
title_full_unstemmed Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
title_short Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
title_sort baicalein protects against endothelial cell injury by inhibiting the tlr4/nf-κb signaling pathway
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783530/
https://www.ncbi.nlm.nih.gov/pubmed/29257294
http://dx.doi.org/10.3892/mmr.2017.8266
work_keys_str_mv AT wanchunxia baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway
AT xuman baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway
AT huangsihui baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway
AT wuqingqing baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway
AT yuanyuan baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway
AT dengwei baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway
AT tangqizhu baicaleinprotectsagainstendothelialcellinjurybyinhibitingthetlr4nfkbsignalingpathway